During the past decade, Dean Hematology and Oncology Clinic conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 35 clinical trials were completed, i.e. on average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 12 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dean Hematology and Oncology Clinic" #1 sponsor was "National Cancer Institute (NCI)" with 39 trials, followed by "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored, "Academic and Community Cancer Research United" with 2 trials sponsored and "Bristol-Myers Squibb" with 2 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dean Hematology and Oncology Clinic" #1 collaborator was "National Cancer Institute (NCI)" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "NCIC Clinical Trials Group" with 4 trials as a collaborator and "North Central Cancer Treatment Group" with 4 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Dean Hematology and Oncology Clinic" are "Recurrent Breast Carcinoma" (6 trials), "Recurrent Melanoma" (4 trials), "Stage IV Breast Cancer AJCC v6 and v7" (4 trials), "Breast Adenocarcinoma" (3 trials) and "Breast Cancer" (3 trials). Many other conditions were trialed in "Dean Hematology and Oncology Clinic" in a lesser frequency.

Most popular intervention types in "Dean Hematology and Oncology Clinic" are "Drug" (47 trials), "Other" (41 trials), "Biological" (30 trials), "Procedure" (8 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (26 trials), "Quality-of-Life Assessment" (17 trials), "Paclitaxel" (11 trials), "Bevacizumab" (10 trials) and "Placebo" (9 trials). Other intervention names were less common.

The vast majority of trials in "Dean Hematology and Oncology Clinic" are 42 trials for "All" genders, 12 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Dean Hematology and Oncology Clinic". undefined are not yet recruiting, 5 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Dean Hematology and Oncology Clinic, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Dean Hematology and Oncology Clinic, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 40 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".